172 related articles for article (PubMed ID: 10858286)
41. The human DNA polymerase lambda interacts with PCNA through a domain important for DNA primer binding and the interaction is inhibited by p21/WAF1/CIP1.
Maga G; Blanca G; Shevelev I; Frouin I; Ramadan K; Spadari S; Villani G; Hübscher U
FASEB J; 2004 Nov; 18(14):1743-5. PubMed ID: 15358682
[TBL] [Abstract][Full Text] [Related]
42. MutLalpha and proliferating cell nuclear antigen share binding sites on MutSbeta.
Iyer RR; Pluciennik A; Genschel J; Tsai MS; Beese LS; Modrich P
J Biol Chem; 2010 Apr; 285(15):11730-9. PubMed ID: 20154325
[TBL] [Abstract][Full Text] [Related]
43. hMSH3 and hMSH6 interact with PCNA and colocalize with it to replication foci.
Kleczkowska HE; Marra G; Lettieri T; Jiricny J
Genes Dev; 2001 Mar; 15(6):724-36. PubMed ID: 11274057
[TBL] [Abstract][Full Text] [Related]
44. Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage.
Li R; Hannon GJ; Beach D; Stillman B
Curr Biol; 1996 Feb; 6(2):189-99. PubMed ID: 8673466
[TBL] [Abstract][Full Text] [Related]
45. Use of peptides from p21 (Waf1/Cip1) to investigate PCNA function in Xenopus egg extracts.
Mattock H; Jares P; Zheleva DI; Lane DP; Warbrick E; Blow JJ
Exp Cell Res; 2001 May; 265(2):242-51. PubMed ID: 11302689
[TBL] [Abstract][Full Text] [Related]
46. Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21.
Podust VN; Podust LM; Goubin F; Ducommun B; Hübscher U
Biochemistry; 1995 Jul; 34(27):8869-75. PubMed ID: 7612628
[TBL] [Abstract][Full Text] [Related]
47. Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 and p21Waf1/Cip1 with PCNA.
Chen IT; Smith ML; O'Connor PM; Fornace AJ
Oncogene; 1995 Nov; 11(10):1931-7. PubMed ID: 7478510
[TBL] [Abstract][Full Text] [Related]
48. Physical interaction between proliferating cell nuclear antigen and replication factor C from Pyrococcus furiosus.
Matsumiya S; Ishino S; Ishino Y; Morikawa K
Genes Cells; 2002 Sep; 7(9):911-22. PubMed ID: 12296822
[TBL] [Abstract][Full Text] [Related]
49. D-type cyclin-binding regions of proliferating cell nuclear antigen.
Matsuoka S; Yamaguchi M; Matsukage A
J Biol Chem; 1994 Apr; 269(15):11030-6. PubMed ID: 7908906
[TBL] [Abstract][Full Text] [Related]
50. Developing peptide-based multivalent antagonists of proliferating cell nuclear antigen and a fluorescence-based PCNA binding assay.
Bozza WP; Yang K; Wang J; Zhuang Z
Anal Biochem; 2012 Aug; 427(1):69-78. PubMed ID: 22522186
[TBL] [Abstract][Full Text] [Related]
51. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor.
Goubin F; Ducommun B
Oncogene; 1995 Jun; 10(12):2281-7. PubMed ID: 7784076
[TBL] [Abstract][Full Text] [Related]
52. Highly potent p21(WAF1)-derived peptide inhibitors of CDK-mediated pRb phosphorylation: delineation and structural insight into their interactions with cyclin A.
Zheleva DI; McInnes C; Gavine AL; Zhelev NZ; Fischer PM; Lane DP
J Pept Res; 2002 Nov; 60(5):257-70. PubMed ID: 12383116
[TBL] [Abstract][Full Text] [Related]
53. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.
Chen J; Jackson PK; Kirschner MW; Dutta A
Nature; 1995 Mar; 374(6520):386-8. PubMed ID: 7885482
[TBL] [Abstract][Full Text] [Related]
54. p21waf1/cip1 protein associates with the detergent-insoluble form of PCNA concomitantly with disassembly of PCNA at nucleotide excision repair sites.
Savio M; Stivala LA; Scovassi AI; Bianchi L; Prosperi E
Oncogene; 1996 Oct; 13(8):1591-8. PubMed ID: 8895503
[TBL] [Abstract][Full Text] [Related]
55. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21.
Cayrol C; Ducommun B
Oncogene; 1998 Nov; 17(19):2437-44. PubMed ID: 9824154
[TBL] [Abstract][Full Text] [Related]
56. p21CDKN1A does not interfere with loading of PCNA at DNA replication sites, but inhibits subsequent binding of DNA polymerase delta at the G1/S phase transition.
Cazzalini O; Perucca P; Riva F; Stivala LA; Bianchi L; Vannini V; Ducommun B; Prosperi E
Cell Cycle; 2003; 2(6):596-603. PubMed ID: 14504476
[TBL] [Abstract][Full Text] [Related]
57. Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.
Watanabe H; Pan ZQ; Schreiber-Agus N; DePinho RA; Hurwitz J; Xiong Y
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1392-7. PubMed ID: 9465025
[TBL] [Abstract][Full Text] [Related]
58. A functional analysis of PCNA-binding peptides derived from protein sequence, interaction screening and rational design.
Warbrick E
Oncogene; 2006 May; 25(20):2850-9. PubMed ID: 16407840
[TBL] [Abstract][Full Text] [Related]
59. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme.
Flores-Rozas H; Kelman Z; Dean FB; Pan ZQ; Harper JW; Elledge SJ; O'Donnell M; Hurwitz J
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8655-9. PubMed ID: 7915843
[TBL] [Abstract][Full Text] [Related]
60. Rational Design of a 3
Wegener KL; McGrath AE; Dixon NE; Oakley AJ; Scanlon DB; Abell AD; Bruning JB
Chemistry; 2018 Aug; 24(44):11325-11331. PubMed ID: 29917264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
